NASDAQ:FENC - Fennec Pharmaceuticals SEC Filings & 10K Form

$4.24
-0.63 (-12.94 %)
(As of 09/16/2019 10:21 AM ET)
Today's Range
$4.91
Now: $4.24
$4.91
50-Day Range
$3.87
MA: $4.43
$4.96
52-Week Range
$3.26
Now: $4.24
$8.74
Volume194 shs
Average Volume12,346 shs
Market Capitalization$84.38 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.03

SEC Filings

Fennec Pharmaceuticals (NASDAQ:FENC) SEC Filings

DateFilerForm TypeView
09/13/2019
10:40 AM
Fennec Pharmaceuticals (Issuer)
Goel Shubh (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/11/2019
5:48 PM
Fennec Pharmaceuticals (Issuer)
Goel Shubh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:13 PM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2019
10:19 AM
Fennec Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2019
10:15 AM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2019
1:59 PM
Fennec Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/20/2019
5:03 AM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
7:34 PM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
7:34 PM
Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
7:33 PM
Fennec Pharmaceuticals (Issuer)
Islam Khalid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
7:33 PM
Brughera Marco Maria (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2019
9:33 AM
Fennec Pharmaceuticals (Filer)
Form DEF 14A
05/10/2019
8:45 AM
Fennec Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2019
3:40 PM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2019
11:35 AM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2019
3:14 PM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2019
10:28 AM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
10:23 AM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2019
12:27 PM
Fennec Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/14/2019
5:02 AM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2019
10:42 AM
683 Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2019
7:31 AM
Fennec Pharmaceuticals (Subject)
venBio Select Advisor LLC (Filed by)
Form SC 13G/A
02/04/2019
1:26 PM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2018
12:32 PM
Fennec Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/22/2018
6:46 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4/A
08/21/2018
2:09 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2018
4:26 PM
Fennec Pharmaceuticals (Subject)
MANCHESTER MANAGEMENT PR, LLC (Filed by)
Form SC 13D/A
08/17/2018
3:33 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2018
1:00 PM
Fennec Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/27/2018
4:23 PM
Fennec Pharmaceuticals (Subject)
MANCHESTER MANAGEMENT PR, LLC (Filed by)
Form SC 13D/A
06/22/2018
3:30 PM
Fennec Pharmaceuticals (Subject)
Opaleye Management Inc. (Filed by)
Form SC 13G
06/11/2018
9:59 AM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2018
9:54 AM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2018
9:44 AM
Fennec Pharmaceuticals (Issuer)
Islam Khalid (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
9:43 AM
Fennec Pharmaceuticals (Issuer)
Haigh Adrian (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
9:41 AM
Brughera Marco Maria (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
9:40 AM
Fennec Pharmaceuticals (Issuer)
RALLIS CHRIS A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2018
11:18 AM
Fennec Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/10/2018
4:27 PM
Fennec Pharmaceuticals (Filer)
Form DEF 14A
04/20/2018
2:14 PM
Fennec Pharmaceuticals (Filer)
Form 424B3
04/19/2018
11:15 PM
Fennec Pharmaceuticals (Filer)
Form EFFECT
04/13/2018
5:04 AM
Fennec Pharmaceuticals (Filer)
Form POS AM
03/29/2018
4:10 PM
BESSER JAMES E (Reporting)
Fennec Pharmaceuticals (Issuer)
FRANK MORGAN C. (Reporting)
Manchester Explorer, L.P. (Reporting)
MANCHESTER MANAGEMENT CO LLC (Reporting)
MANCHESTER MANAGEMENT PR, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
4:07 PM
BESSER JAMES E (Reporting)
Fennec Pharmaceuticals (Issuer)
FRANK MORGAN C. (Reporting)
Manchester Explorer, L.P. (Reporting)
MANCHESTER MANAGEMENT CO LLC (Reporting)
MANCHESTER MANAGEMENT PR, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
4:03 PM
BESSER JAMES E (Reporting)
Fennec Pharmaceuticals (Issuer)
FRANK MORGAN C. (Reporting)
Manchester Explorer, L.P. (Reporting)
MANCHESTER MANAGEMENT CO LLC (Reporting)
MANCHESTER MANAGEMENT PR, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
3:59 PM
BESSER JAMES E (Reporting)
Fennec Pharmaceuticals (Issuer)
FRANK MORGAN C. (Reporting)
Manchester Explorer, L.P. (Reporting)
MANCHESTER MANAGEMENT CO LLC (Reporting)
MANCHESTER MANAGEMENT PR, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
3:55 PM
Fennec Pharmaceuticals (Issuer)
MANCHESTER MANAGEMENT PR, LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/29/2018
3:51 PM
BESSER JAMES E (Reporting)
Fennec Pharmaceuticals (Issuer)
FRANK MORGAN C. (Reporting)
Manchester Explorer, L.P. (Reporting)
MANCHESTER MANAGEMENT CO LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
3:48 PM
BESSER JAMES E (Reporting)
Fennec Pharmaceuticals (Issuer)
FRANK MORGAN C. (Reporting)
Manchester Explorer, L.P. (Reporting)
MANCHESTER MANAGEMENT CO LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
3:47 PM
BESSER JAMES E (Reporting)
Fennec Pharmaceuticals (Issuer)
FRANK MORGAN C. (Reporting)
Manchester Explorer, L.P. (Reporting)
MANCHESTER MANAGEMENT CO LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
3:45 PM
BESSER JAMES E (Reporting)
Fennec Pharmaceuticals (Issuer)
FRANK MORGAN C. (Reporting)
Manchester Explorer, L.P. (Reporting)
MANCHESTER MANAGEMENT CO LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2018
3:41 PM
Fennec Pharmaceuticals (Subject)
MANCHESTER MANAGEMENT PR, LLC (Filed by)
Form SC 13D/A
03/28/2018
4:25 PM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2018
3:47 PM
Fennec Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/23/2018
2:12 PM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2018
10:43 AM
683 Capital Management, LLC (Filed by)
Fennec Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2018
3:22 PM
Fennec Pharmaceuticals (Subject)
venBio Select Advisor LLC (Filed by)
Form SC 13G
02/08/2018
8:03 PM
Fennec Pharmaceuticals (Issuer)
Raykov Rosty (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2018
8:02 PM
Andrade Robert (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2017
3:16 PM
Essetifin SPA (Filed by)
Fennec Pharmaceuticals (Subject)
Form SC 13D
12/14/2017
3:15 PM
Cavazza Enrico (Reporting)
Cavazza Francesca (Reporting)
CAVAZZA PAOLO (Reporting)
Cavazza Preta Martina (Reporting)
Cavazza Silvia (Reporting)
Essetifin SPA (Reporting)
Fennec Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2017
1:58 PM
Fennec Pharmaceuticals (Filer)
Form 424B5
12/11/2017
1:51 PM
Fennec Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2017
3:05 PM
Fennec Pharmaceuticals (Subject)
Form FWP
12/07/2017
3:05 PM
Fennec Pharmaceuticals (Filer)
Form 424B5
This page was last updated on 9/16/2019 by MarketBeat.com Staff

Featured Article: What are no-load funds?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel